- Online training -
Webcode 25112456
Dr. Oliver Brehm
Consultant
Dr Brehm was employed in the Pharmaceuticals and Consumer Health divisions at Bayer Group for 30 years. He worked as a production manager, was involved in drug development and approval. He was responsible for global quality management for both Pharmaceuticals and ConsumerHealth in Germany and abroad. Until 2024 he was Chief Quality Officer of Bayer AG and now works as an independent consultant in the areas of GxP, Quality Management and TechOps Pharma.
Dr. Steffen Groß
Paul-Ehrlich-Institut (PEI), Langen
Dr Gross has extensive experience in molecular and cell biology. In his current position, he is involved in the assessment of the quality and preclinical issues for marketing authorisation applications, scientific advices and clinical trial applications.
Dr. Helmut Vigenschow
ViPharmaService, Burgrieden
Independent Consultant Dr Vigenschow worked for Merckle/ratiopharm for 30 years in leading positions, including in the areas of project management, regulatory affairs, pharmaceutical development, quality assurance and quality control. Dr Vigenschow has been working as an independent consultant for several years now.
20/11/2025
20/11/2025
9:00 am - 5:00 pm Online training
You may dial in 30 minutes before the training starts
online
online
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Dr. Birgit Wessels
Conference Manager
+49 6221 500-652
b.wessels@forum-institut.de
To make the most of ICH Q12 opportunities, you have to be aware of the relation between ICH guidelines Q8 to Q12 and how to properly integrate them. Our experts will go through each guideline and train you on the desired outcome of mastering the processes from development to lifecycle management and especially QbD.
You are involved in product lifecycle management processes? Stop asking if Quality by Design is mandatory or needed! Our three experts will sensitise you not to underestimate any longer what you can in fact get from it.
To make the most of ICH Q12 opportunities you have to be aware of the relation between ICH guidelines Q8 to Q12 and how to properly integrate them. It's absolutely critical that you understand the need of mastering the different Quality by Design (QbD) options and that you realise their implications.
Our experts will go through each guideline with focus on ICH Q8 (drug product) and ICH Q11 (drug substance). They will point out the specific challenges with interpretation and implementation and the relation between all guidelines.
In the end you will be trained in a more conceptional way on the desired outcome of mastering QbD to make the most of ICH Q12.
After participating in this seminar you will be aware of the relation between the guidelines ICH Q8 to ICH Q12. This will enable you to recognise the opportunities of ICH Q12 and to profitably put the requirements of the guideline into practice.
09:00 Opening and introduction round
09:15
Dr Steffen Groß
09:45
Dr Steffen Groß
10:20 Coffee break
10:30
Dr Oliver Brehm
12:30 Lunch break
13:30
Dr Helmut Vigenschow
15:00
Dr Helmut Vigenschow
16:15 Coffee break
16:30
Dr Steffen Groß, Dr Oliver Brehm
17:00 End of the training
Seit 2000 bieten wir Expertenwissen zu verschiedenen Rechtsthemen in englischer und deutscher Sprache an. Zu unseren Kernkompetenzen gehören u.a. das Stoff- und Chemikalienrecht sowie das Pharmarecht.
Asphalion is an international Scientific and RA consultancy company. Founded in 2000, Asphalion offers comprehensive services for Drug Development and RA to Pharma, Biotech and Medical Devices companies. The services range from early development, throughout the registration, until marketing and post-commercialization phases of a product.
This course can be choosen as elective module within the modular qualification training course "CMC-Specialist in Regulatory Affairs".
The concept:
- First you visit the mandatory module "Der CMC-Manager in Regulatory Affairs"
- Further you choose another three elective modules (= three training days) dealing with CMC related topics from our portfolio
- Thus you receive a structured training in CMC/Regulatory Affairs topics
- Thus you are able to qualify yourself individually according to your focus of activities
Please visit our webpage Website
FORUM Institut’s all-in-one training platform uses the latest teaching methods.
All our online training courses take place in the Learning Space, our holistic learning environment with many features that promote effective and sustainable learning.
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
The Good Pharmacovigilance Practices modules (GVP modules) by the European Medicines Agency (EMA) serve as a reference f...
This online training offers comprehensive insights into Regulatory Affairs, CMC, and GMP requirements, with a focus on t...
Join our interactive course to explore how AI is transforming pharmacovigilance. Take part in discussions, hands-on work...
The compact course with a content focus on the development, production and analytics of biotech drugs. Secure your place...
This course familiarises you with regulatory post-approval duties and provides first-hand information on variation submi...
We are now officially certified to ISO 9001 and ISO 21001 standard.
Details
